RE:RE:RE:12/13 Goblet PC patients had Stage IV metastatic (M1) cancerThe patient that demonstrated a CR at week 40 (end-of-trial) was patient #C1-002 a 54 year old male who had his cancer spread to his pertonieum.
The others had experienced partial responses (PR) to their cancer.
Best responses for the 13 evaluable patients at cut-off date: CR=1, PR=8, SD=2 and PD=2. Of the 9 patients with CR or PR, 7 responses were confirmed by a subsequent scan. ORR and clinical benefit rate (CBR) are 69% and 85%, respectively. Largest tumor diameter decreased from 30 mm at baseline to too small to measure at Week 24.